Status:
COMPLETED
Pepsinogens as the Early Marker of H. Pylori Eradication
Lead Sponsor:
Hamamatsu University
Conditions:
H. Pylori Infection
Gastric Ulcer
Eligibility:
All Genders
20-90 years
Phase:
PHASE2
Brief Summary
Helicobacter pylori (H. pylori) eradication increases the serum pepsinogen (PG) I/PG II ratio and the percentage change in PG I/PG II ratios was found to be a useful marker of H. pylori eradication (e...
Eligibility Criteria
Inclusion
- Patients with H. pylori infection
Exclusion
- Patients without H. pylori infection
Key Trial Info
Start Date :
June 1 2001
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00197457
Start Date
June 1 2001
Last Update
February 1 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamamatsu University School of Medicine
Hamamatsu, Shizuoka, Japan, 431-3192